• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼皮肤白化病相关酪氨酸酶突变体的温度依赖性动力学特征

Characterization of Temperature-Dependent Kinetics of Oculocutaneous Albinism-Causing Mutants of Tyrosinase.

作者信息

Wachamo Samuel A, Patel Milan H, Varghese Paul K, Dolinska Monika B, Sergeev Yuri V

机构信息

National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Int J Mol Sci. 2021 Jul 21;22(15):7771. doi: 10.3390/ijms22157771.

DOI:10.3390/ijms22157771
PMID:34360537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8346126/
Abstract

Human tyrosinase (Tyr) is a glycoenzyme that catalyzes the first and rate-limiting step in melanin production, and its gene () is mutated in many cases of oculocutaneous albinism type 1 (OCA1). The mechanisms by which individual mutations contribute to the diverse pigmentation phenotype in patients with OCA1 have only began to be examined and remain to be delineated. Here, we analyze the temperature-dependent kinetics of wild-type Tyr (WT) and two OCA1B mutant variants (R422Q and P406L) using Michaelis-Menten and Van't Hoff analyses. Recombinant truncated human Tyr proteins (residues 19-469) were produced in the whole insect larvae. Proteins were purified by a combination of affinity and size-exclusion chromatography. The temperature dependence of diphenol oxidase protein activities and kinetic parameters were measured by dopachrome absorption. Using the same experimental conditions, computational simulations were performed to assess the temperature-dependent association of L-DOPA and Tyr. Our results revealed, for the first time, that the association of L-DOPA with R422Q and P406L followed by dopachrome formation is a complex reaction supported by enthalpy and entropy forces. We show that the WT has a higher turnover number as compared with both R422Q and P406L. Elucidating the kinetics and thermodynamics of mutant variants of Tyr in OCA1B helps to understand the mechanisms by which they lower Tyr catalytic activity and to discover novel therapies for patients.

摘要

人类酪氨酸酶(Tyr)是一种糖酶,它催化黑色素生成的第一步且是限速步骤,在许多1型眼皮肤白化病(OCA1)病例中其基因()发生突变。OCA1患者中个体突变导致不同色素沉着表型的机制才刚刚开始研究,仍有待阐明。在此,我们使用米氏分析和范特霍夫分析来分析野生型Tyr(WT)以及两种OCA1B突变变体(R422Q和P406L)的温度依赖性动力学。重组截短的人类Tyr蛋白(第19 - 469位氨基酸残基)在全昆虫幼虫中产生。蛋白质通过亲和色谱和尺寸排阻色谱相结合的方法进行纯化。通过多巴色素吸收来测量二酚氧化酶蛋白活性和动力学参数的温度依赖性。在相同实验条件下,进行计算模拟以评估L - 多巴与Tyr的温度依赖性结合。我们的结果首次揭示,L - 多巴与R422Q和P406L结合后形成多巴色素是一个由焓和熵力支持的复杂反应。我们表明,与R422Q和P406L相比,WT具有更高的周转数。阐明OCA1B中Tyr突变变体的动力学和热力学有助于理解它们降低Tyr催化活性的机制,并为患者发现新的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5350/8346126/567fd36d9eb7/ijms-22-07771-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5350/8346126/8a3f53907e84/ijms-22-07771-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5350/8346126/fe3ca3b5423d/ijms-22-07771-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5350/8346126/6936915b0b71/ijms-22-07771-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5350/8346126/004744830f09/ijms-22-07771-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5350/8346126/e1b74fca46f3/ijms-22-07771-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5350/8346126/6382671126fe/ijms-22-07771-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5350/8346126/567fd36d9eb7/ijms-22-07771-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5350/8346126/8a3f53907e84/ijms-22-07771-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5350/8346126/fe3ca3b5423d/ijms-22-07771-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5350/8346126/6936915b0b71/ijms-22-07771-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5350/8346126/004744830f09/ijms-22-07771-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5350/8346126/e1b74fca46f3/ijms-22-07771-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5350/8346126/6382671126fe/ijms-22-07771-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5350/8346126/567fd36d9eb7/ijms-22-07771-g007.jpg

相似文献

1
Characterization of Temperature-Dependent Kinetics of Oculocutaneous Albinism-Causing Mutants of Tyrosinase.眼皮肤白化病相关酪氨酸酶突变体的温度依赖性动力学特征
Int J Mol Sci. 2021 Jul 21;22(15):7771. doi: 10.3390/ijms22157771.
2
Albinism-causing mutations in recombinant human tyrosinase alter intrinsic enzymatic activity.重组人酪氨酸酶中导致白化病的突变会改变其内在酶活性。
PLoS One. 2014 Jan 2;9(1):e84494. doi: 10.1371/journal.pone.0084494. eCollection 2014.
3
Human Tyrosinase: Temperature-Dependent Kinetics of Oxidase Activity.人酪氨酸酶:氧化酶活性的温度依赖性动力学。
Int J Mol Sci. 2020 Jan 30;21(3):895. doi: 10.3390/ijms21030895.
4
Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.1型眼皮肤白化病:突变、酪氨酸酶构象稳定性与酶活性之间的联系。
Pigment Cell Melanoma Res. 2017 Jan;30(1):41-52. doi: 10.1111/pcmr.12546.
5
Tyrosinase Nanoparticles: Understanding the Melanogenesis Pathway by Isolating the Products of Tyrosinase Enzymatic Reaction.酪氨酸酶纳米颗粒:通过分离酪氨酸酶酶促反应的产物来了解黑色素生成途径。
Int J Mol Sci. 2021 Jan 13;22(2):734. doi: 10.3390/ijms22020734.
6
Membrane-associated human tyrosinase is an enzymatically active monomeric glycoprotein.膜结合人酪氨酸酶是一种具有酶活性的单体糖蛋白。
PLoS One. 2018 Jun 5;13(6):e0198247. doi: 10.1371/journal.pone.0198247. eCollection 2018.
7
The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation.1型眼皮肤白化病(OCA1)的分子基础:突变型酪氨酸酶的分选失败和降解导致色素缺乏。
Biochem J. 2001 Apr 15;355(Pt 2):259-69. doi: 10.1042/0264-6021:3550259.
8
Tyrosinase and ocular diseases: some novel thoughts on the molecular basis of oculocutaneous albinism type 1.酪氨酸酶与眼部疾病:关于1型眼皮肤白化病分子基础的一些新见解
Prog Retin Eye Res. 2007 Jul;26(4):323-58. doi: 10.1016/j.preteyeres.2007.01.001. Epub 2007 Jan 17.
9
Functional assessment of tyrosinase variants identified in individuals with albinism is essential for unequivocal determination of genotype-to-phenotype correlation.对白化病患者中发现的酪氨酸酶变体进行功能评估对于明确基因型-表型相关性至关重要。
Br J Dermatol. 2016 Dec;175(6):1232-1242. doi: 10.1111/bjd.14977. Epub 2016 Nov 11.
10
Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.眼皮肤白化病1型(OCA1)中的酪氨酸酶基因突变:表型的定义
Hum Genet. 2003 Nov;113(6):502-13. doi: 10.1007/s00439-003-0998-1. Epub 2003 Sep 10.

引用本文的文献

1
Genetic mutations disrupt the coordinated mode of tyrosinase's intra-melanosomal domain.基因突变破坏了酪氨酸酶黑素小体内结构域的协同模式。
Protein Sci. 2025 Aug;34(8):e70209. doi: 10.1002/pro.70209.
2
Genetic mutations disrupt the coordinated mode of tyrosinase intra-melanosomal domain.基因突变破坏了酪氨酸酶黑素小体内结构域的协同模式。
bioRxiv. 2025 Apr 25:2025.04.21.649833. doi: 10.1101/2025.04.21.649833.
3
Structural and functional analysis of a homotrimeric collagen peptide.一种同源三聚体胶原蛋白肽的结构与功能分析

本文引用的文献

1
Functional analysis of human tyrosinase and OCA1 associated mutations.人类酪氨酸酶及眼皮肤白化病1型相关突变的功能分析
J Anal Pharm Res. 2020;9(3):81-89. Epub 2020 Aug 24.
2
Tyrosinase Nanoparticles: Understanding the Melanogenesis Pathway by Isolating the Products of Tyrosinase Enzymatic Reaction.酪氨酸酶纳米颗粒:通过分离酪氨酸酶酶促反应的产物来了解黑色素生成途径。
Int J Mol Sci. 2021 Jan 13;22(2):734. doi: 10.3390/ijms22020734.
3
Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations.
Front Bioeng Biotechnol. 2025 Apr 28;13:1575341. doi: 10.3389/fbioe.2025.1575341. eCollection 2025.
4
Molecular Characterization of Oculocutaneous Albinism in Consanguineous Pakistani Families: Unraveling Disease-Causing Pathogenic Variants in OCA2 and TYR Genes for Precision Diagnosis.巴基斯坦近亲家庭中眼皮肤白化病的分子特征:揭示OCA2和TYR基因中致病的致病变异以实现精准诊断。
Biochem Genet. 2025 May 9. doi: 10.1007/s10528-025-11113-3.
5
Molecular Modeling of the Multiple-Substrate Activity of the Human Recombinant Intra-Melanosomal Domain of Tyrosinase and Its OCA1B-Related Mutant Variant P406L.人源酪氨酸酶跨黑素体结构域及其 OCA1B 相关突变体 P406L 的多底物活性的分子建模
Int J Mol Sci. 2024 Mar 16;25(6):3373. doi: 10.3390/ijms25063373.
6
Evaluating the Application Potential of a Recombinant Protein as Bioactive Ingredients in Cosmetics.评估一种重组蛋白作为化妆品中生物活性成分的应用潜力。
Molecules. 2023 Apr 6;28(7):3272. doi: 10.3390/molecules28073272.
7
In Vitro Reconstitution of the Melanin Pathway's Catalytic Activities Using Tyrosinase Nanoparticles.利用酪氨酸酶纳米颗粒在体外重建黑色素途径的催化活性。
Int J Mol Sci. 2022 Dec 30;24(1):639. doi: 10.3390/ijms24010639.
8
Identification of the Key Enzymes in WL Gum Biosynthesis and Critical Composition in Viscosity Control.结冷胶生物合成关键酶的鉴定及黏度控制中的关键成分
Front Bioeng Biotechnol. 2022 May 27;10:918687. doi: 10.3389/fbioe.2022.918687. eCollection 2022.
真人类酪氨酸酶抑制剂的设计进展及其在黑色素生成和相关色素沉着中的靶向作用。
J Med Chem. 2020 Nov 25;63(22):13428-13443. doi: 10.1021/acs.jmedchem.0c00994. Epub 2020 Aug 17.
4
Human Tyrosinase: Temperature-Dependent Kinetics of Oxidase Activity.人酪氨酸酶:氧化酶活性的温度依赖性动力学。
Int J Mol Sci. 2020 Jan 30;21(3):895. doi: 10.3390/ijms21030895.
5
The Molecular Basis of Chemical Chaperone Therapy for Oculocutaneous Albinism Type 1A.1A 型眼皮肤白化病的化学伴侣治疗的分子基础。
J Invest Dermatol. 2019 May;139(5):1143-1149. doi: 10.1016/j.jid.2018.10.033. Epub 2018 Nov 14.
6
Modulation of allosteric coupling by mutations: from protein dynamics and packing to altered native ensembles and function.变构偶联的突变调节:从蛋白质动力学和堆积到改变天然集合体和功能。
Curr Opin Struct Biol. 2019 Feb;54:1-9. doi: 10.1016/j.sbi.2018.09.004. Epub 2018 Sep 28.
7
Effects of Distal Mutations on the Structure, Dynamics and Catalysis of Human Monoacylglycerol Lipase.人单酰甘油脂肪酶结构、动态及催化的远端突变影响。
Sci Rep. 2018 Jan 29;8(1):1719. doi: 10.1038/s41598-017-19135-7.
8
Purification of Recombinant Human Tyrosinase from Insect Larvae Infected with the Baculovirus Vector.从感染杆状病毒载体的昆虫幼虫中纯化重组人酪氨酸酶
Curr Protoc Protein Sci. 2017 Aug 1;89:6.15.1-6.15.12. doi: 10.1002/cpps.37.
9
In silico Mapping of Protein Unfolding Mutations for Inherited Disease.蛋白质错误折叠突变的计算映射在遗传性疾病中的应用
Sci Rep. 2016 Dec 1;6:37298. doi: 10.1038/srep37298.
10
Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.1型眼皮肤白化病:突变、酪氨酸酶构象稳定性与酶活性之间的联系。
Pigment Cell Melanoma Res. 2017 Jan;30(1):41-52. doi: 10.1111/pcmr.12546.